Journal of Hematology & Oncology | |
Hematology research output from Chinese authors and other countries: a 10-year survey of the literature | |
Bao-hua Qian2  An-mei Deng1  Yi Sun1  Xin Ye2  Lei Zhang1  | |
[1] Department of Laboratory Diagnosis, Changhai hospital, Second Military Medical University, Shanghai 200433, China;Department of Transfusion Medicine, Changhai hospital, Second Military Medical University, Shanghai 200433, China | |
关键词: Science Citation Index Expanded (SCIE); Citations; Impact factor; Publications; Hematology; | |
Others : 1133372 DOI : 10.1186/s13045-014-0103-3 |
|
received in 2014-12-02, accepted in 2014-12-30, 发布年份 2015 | |
【 摘 要 】
Background
Hematologic disease affects people of all ages worldwide. In the past decade, researchers have made great progress in the field of hematology. In the present study we compared the hematology research output from China and other countries (USA, Germany, UK, Japan and South Korea) over the past 10 years and 5 years.
Methods
The related articles were extracted based on the PubMed database. We recorded the number of publications, clinical trials, randomized controlled trials, meta-analyses, case reports, reviews, citations, impact factors, articles in the top 10 journals and most published journals to assess the quantity and quality of research output in each region.
Results
A total of 120,641 hematology-related articles were published from 2004 to 2013. The USA accounted for 27.13% (32,732/120,641) of the publications, followed by Germany (7,479/120,641; 6.20%), Japan (6,347/120,641; 5.26%), the UK (5,453/120,641; 4.52%), China (2,924/120,641; 2.42%) and South Korea (1,413/120,641; 1.17%). The ranking for cumulative impact factors was as follows: USA; Germany; UK; Japan; China and South Korea. The median impact factors in the UK, USA, and Germany were higher than Japan, South Korea, and China. Interestingly, the median impact factors in the three Asia countries were similar both in 2004–2013 and 2009–2013. The UK had the highest percentage of publications in the top 25% of journals, while China lagged behind and ranked last. When comparing the number of articles in the top 10 journals, the results were similar to the IF findings. Germany had the highest number of average citations, while China had the lowest number of average citation. The status of hematology research output from the 6 countries in 2009–2013 had little difference from 2004–2013.
Conclusions
Thus, the USA has had a dominant role in hematologic research in the past 10 years. Overall, the quality of publications in European countries was better than Asia countries. Although China has made considerable progress in hematology research, the quality of research needs improvement.
【 授权许可】
2015 Zhang et al.; licensee Biomed Central.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150304142946809.pdf | 870KB | download | |
Figure 3. | 20KB | Image | download |
Figure 2. | 22KB | Image | download |
Figure 1. | 61KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
【 参考文献 】
- [1]World Health Organization. World health statistics. 2014.
- [2]Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al.: Rapid health transition in china, 1990–2010: Findings from the global burden of disease study 2010. Lancet 2010, 381:1987-2015.
- [3]National Health and Family Planning Commission of The People's Republic of China. 2013 china health statistical yearbook. [Http://www.Nhfpc.Gov.Cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.Html].
- [4]Chinese Institute of Scientific and Technical Information. Statistical data of chinese s&t papers. 2013;[http://www.Istic.Ac.Cn/portals/0/documents/kxpj/2%e5%9b%bd%e9%99%85.pdf].
- [5]Rethlefsen ML, Murad MH, Livingston EH: Engaging medical librarians to improve the quality of review articles. Jama 2014, 312:999-1000.
- [6]The Economist. R&D in China: Research and embezzlement. [http://www.economist.com/blogs/analects/2014/03/rd-china].
- [7]The State Council of The People's Republic of China. National medium-and long-term programme for scientific and technological development (2006–2020). [http://www.gov.cn/jrzg/2006-02/09/content_183787_2.htm].
- [8]Green JB: Limiting the impact of the impact factor. Science 2008, 322:1463.
- [9]Cherubini P: Impact factor fever. Science 2008, 322:191.
- [10]Chen S, Pan Y, Yao Q, Yao L, Liu Z, Xiang L: Publication pressure on chinese doctors–another view. Lancet 2014, 384:956.
- [11]Ye B, Liu AH: Inadequate evaluation of medical doctors in china. Lancet 2013, 381:1984.